🌍🦟On the eve of #WorldMosquitoDay, we emphasize the critical role of diagnostics in managing arboviruses like Chikungunya and Dengue. Accurate and timely methods are crucial for early detection, effective treatment, and outbreak control. 🔎 Explore our new monographs to enhance your knowledge and improve patient management: 👉 http://spkl.io/60424hN3y
bioMérieux
Recherche en biotechnologie
Marcy-l'Étoile, Auvergne-Rhône-Alpes 325 103 abonnés
Pioneering Diagnostics
À propos
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP
- Seite web
-
https://www.biomerieux.com
Lien externe pour bioMérieux
- Secteur
- Recherche en biotechnologie
- Größe des Unternehmens
- + de 10 000 Beschäftigte
- Siège social
- Marcy-l'Étoile, Auvergne-Rhône-Alpes
- Typ
- Börsennotierte Gesellschaft
- Fondée en
- 1963
- Domains
- in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank et sepsis
Lieux
Employés chez bioMérieux
Nouvelles
-
Congratulations to our partner SpinChip Diagnostics ASA for the publication of fantastic clinical and analytical performance results of its POC high sensitivity cardiac Troponin assay in the renowned Journal of the American College of Cardiology (JACC Journals). 👉 The conclusion of the JACC editorial is self-speaking: “In conclusion, the hs-cTnI-SPINCHIP POCT assay offers a promising advancement in the rapid and accurate diagnosis of MI, with significant potential to improve patient outcomes and streamline workflow in the ED." 📰 Read SpinChip latest press release to learn more: https://lnkd.in/ejGdvTyY
-
Last month, our #FoodSafety teams participated in the International Association for Food Protection Annual Meeting at the Long Beach Convention Center in the U.S. 👉 This event brought together over 3,500 leading food safety experts from industry, academia, and government, all united in the mission to advance food safety. Congrats to all the teams involved for your contribution in advancing the fight against infectious diseases! 👏 #WeArebioMérieux
-
-
Our Chinese Supply Chain team successfully hosted the 4th Climate Fresk mid July, during the Clinical Applications team’s meeting held in Chongqing, China. This awareness workshop was an opportunity for our distributors across China to actively participate, alongside with our local teams. The session was characterized by meaningful exchanges and innovative ideas for immediate actions to preserve the planet as a healthy place to live. 🌏 A huge thank you to all the teams involved for their support and dedication for making this workshop a success! 👏 #WeArebioMérieux #WeActForAPositiveImpact
-
-
🤒 Often, illnesses in children can be treated at home with rest, fluids, and over-the-counter medicines. However, sometimes an infection can be more severe, necessitating the support of a healthcare team. Visit our blog to learn about the vital role of #diagnostics in patient care for kids and how accurately identifying the causative pathogen can help support patient care and curb #AntimicrobialResistance. 👉 http://spkl.io/60464hzO4
-
-
Did you know that many of our team members are also talented artists? Here’s another great example! 🎭 After a year of teamwork and preparation, a dozen of our Italian colleagues took to the stage to perform a play by Cervantes for their peers. Not only was this event a fantastic team-bonding experience, but it also supported a great cause! 💕 👉 Every ticket sold will contribute to Railway Children, a #charity committed to helping vulnerable children alone and at risk on the streets and at transport hubs. Congratulations to all the actors for this amazing initiative! #WeArebioMérieux
-
🎉 The Paris 2024 Olympic Games kicked off this week! Did you know that some national delegations will use our syndromic solutions to test athletes during the competition? 👉 For example, the Dutch medical team has set up a mini-laboratory in the Olympic Village, equipped with a BIOFIRE® FILMARRAY® TORCH system to detect gastrointestinal infections and a BIOFIRE® SPOTFIRE® instrument to detect respiratory sore/throat infections. The Paris Games involve over 15,000 athletes along with their support staff, making it critical to isolate anyone who is infected and potentially contagious in order to prevent the spread of disease. Diagnostics continue to be a game changer – and a golden champion! – to fight against infectious diseases and preserve public health during big sporting competitions. 🏅 💡 Read more on: https://lnkd.in/eDHneDHH #PioneeringDiagnostics
Paris 2024: National teams choose bioMérieux’s BIOFIRE® PCR solutions to test athletes
biomerieux.com
-
The bioMérieux Urgency Tour has begun! 🏁 Team members from our French subsidiary embarked on a year-long journey to bring innovation directly to hospital doorsteps! 🚛 This special truck was inaugurated in Lyon, at our Craponne site, and during the French Annual Meeting. Soon, the team will connect with healthcare professionals across the country, allowing them to test clinical samples in real-time and share valuable experiences. Stay tuned for more updates and see you on the road! #PioneeringDiagnostics
-
-
Antimicrobial Resistance (AMR) impacts everyone. When her daughter was diagnosed with leukemia, Menia Koukougianni didn’t know she would also need to worry about AMR. 👉 Discover her story in our new blog article: https://lnkd.in/eeQd5X88
-
-
Celebrating Excellence at bioMérieux! ✨ Recently, we welcomed our 2023 Chairman’s Circle and bioSTAR award winners to France for two special week-long events! 🙌 Our top sales performers and premier channel partners were celebrated during two exclusive events designed to recognize and reward their outstanding achievements, foster connections with colleagues and leaders, highlight our unique history of innovation, and strengthen the bioMérieux global community – all while enjoying the cuisine and culture of France! Congratulations to all the winners! You are truly elevating the experience we deliver to our valued customers and boldly contributing to our mission to help make the world a healthier place! 👏 #WeArebioMérieux
-